Skip to main content

Advertisement

Table 1 Patient characteristics

From: Determination of caspase-3 activation fails to predict chemosensitivity in primary acute myeloid leukemia blasts

Patients diagnosed with AML, no 42
Age [years]: median (range) 45 (19 – 73)
Female/male ratio, no 16/26
Successful DiSC-assays, no (%) 37/42 (88%)
Successful Casp3-tests, no (%) 42/42 (100%)
   Successful single drug tests, no (%) 116/126 (92%)
DiSC-assay / Casp3-test correlation, no (%) 37/42 (88%)
   Correlation between single drugs, no (%) 94/126 (75%)
FAB-groups No
M1 3
M2 12
M3 4
M4 10
M5 5
M6 1
Secondary AML 7